Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients

Table 3

Characteristics of patients that received PCP prophylaxis.

Gender	Age (years)	Prophylaxis used	Baseline disease	Steroid use	Other immunosuppressants
Male	20	Inhaled pentamidine	Hematological malignancy	No	Tacrolimus
Male	61	Inhaled pentamidine	Hematological malignancy	Only with chemotherapy	Methotrexate, mercaptopurina, and vincristine
Female	68	Inhaled pentamidine	Hematological malignancy	Only with chemotherapy	ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Male	72	TMP-SMX (SS); 3x per week	Transplant; (Renal and liver)	Daily (5 mg a day)	Tacrolimus and mycophenolate mofetil
Male	46	TMP-SMX (DS); 2x per week	Inflammatory	Daily (30 mg a day)	Azathioprine
Male	29	TMP-SMX (SS); Once a day	Transplant; (Lung)	Daily (10 mg a day)	Cyclosporine and azathioprine
Female	27	TMP-SMX (SS); After dialysis	Inflammatory	Daily (10 mg a day)	No

Prednisone equivalent.